Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021
Cash flows from operating activities
Net income	$ 99.4	$ 455.6
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	123.5	122.9
Amortization of unfavorable contracts	(1.4)	(2.9)
Share-based compensation	34.3	36.4
Deferred taxation	63.2	(20.1)
Pension settlement loss	132.8	0.0
Other non-cash movements	7.8	4.0
Changes in operating assets and liabilities, net of acquisitions:
(Increase) decrease in accounts receivable	(9.9)	13.0
Proceeds from sale of in-house finance receivables	0.0	81.3
Decrease (increase) in other assets and other receivables	0.6	(12.9)
Increase in inventories	(305.6)	(112.1)
(Decrease) increase in accounts payable	(177.6)	36.8
Increase (decrease) in accrued expenses and other liabilities	105.6	(25.6)
Change in operating lease assets and liabilities	(5.9)	(59.9)
(Decrease) increase in deferred revenue	(7.0)	47.1
Change in income tax receivable and payable	(206.1)	(67.3)
Pension plan contributions	(9.2)	(12.4)
Net cash (used in) provided by operating activities	(155.5)	483.9
Investing activities
Purchase of property, plant and equipment	(94.3)	(50.5)
Acquisitions, net of cash acquired	(397.8)	(14.6)
Other investing activities, net	(16.3)	2.1
Net cash used in investing activities	(508.4)	(63.0)
Financing activities
Dividends paid on common shares	(27.4)	(9.5)
Dividends paid on redeemable convertible preferred shares	(24.6)	(16.4)
Repurchase of common shares	(311.2)	(41.1)
Payment of debt issuance costs	0.0	(3.9)
Increase of bank overdrafts	0.0	0.3
Other financing activities, net	(44.3)	(7.5)
Net cash used in financing activities	(407.5)	(78.1)
Cash and cash equivalents at beginning of period	1,418.3	1,172.5
(Decrease) increase in cash and cash equivalents	(1,071.4)	342.8
Effect of exchange rate changes on cash and cash equivalents	(19.6)	1.6
Cash and cash equivalents at end of period	$ 327.3	$ 1,516.9